EE226 A US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Common Comorbidities, Acute Medication Overuse, or Difficult-to-Treat Migraine Following Prior Erenumab ...
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.474
https://www.valueinhealthjournal.com/article/S1098-3015(22)00675-1/fulltext
Section Title :
Section Order :
10421
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00675-1&doi=10.1016/j.jval.2022.04.474